Role of Extracellular Vesicles in Chronic Lung Disease

Overview

Journal Thorax

Date 2021 Mar 13

PMID 33712504

Citations 24

Authors

Anne Trappe

Seamas C Donnelly

Paul McNally

Judith A Coppinger

Affiliations

Soon will be listed here.

Abstract

To explore the role of extracellular vesicles (EVs) in chronic lung diseases.EVs are emerging as mediators of intercellular communication and possible diagnostic markers of disease. EVs harbour cargo molecules including RNA, lipids and proteins that they transfer to recipient cells. EVs are intercellular communicators within the lung microenvironment. Due to their disease-specific cargoes, EVs have the promise to be all-in-one complex multimodal biomarkers. EVs also have potential as drug carriers in chronic lung disease.Descriptive discussion of key studies of EVs as contributors to disease pathology, as biomarkers and as potential therapies with a focus on chronic obstructive pulmonary disorder (COPD), cystic fibrosis (CF), asthma, idiopathic pulmonary fibrosis and lung cancer.We provide a broad overview of the roles of EV in chronic respiratory disease. Recent advances in profiling EVs have shown their potential as biomarker candidates. Further studies have provided insight into their disease pathology, particularly in inflammatory processes across a spectrum of lung diseases. EVs are on the horizon as new modes of drug delivery and as therapies themselves in cell-based therapeutics.EVs are relatively untapped sources of information in the clinic that can help further detail the full translational nature of chronic lung disorders.

Citing Articles

Respiratory extracellular vesicle isolation optimization through proteomic profiling of equine samples and identification of candidates for cell-of-origin studies.

Hickman E, Carberry V, Carberry C, Cooper B, Mordant A, Mills A PLoS One. 2025; 20(1):e0315743.

PMID: 39854355 PMC: 11760557. DOI: 10.1371/journal.pone.0315743.

Extracellular vesicles in sputum of children with cystic fibrosis pulmonary exacerbations.

Ben-Meir E, Antounians L, Eisha S, Ratjen F, Zani A, Grasemann H ERJ Open Res. 2024; 10(6).

PMID: 39655173 PMC: 11626615. DOI: 10.1183/23120541.00547-2024.

Extracellular Vesicles in Idiopathic Pulmonary Fibrosis: Pathogenesis, Biomarkers and Innovative Therapeutic Strategies.

Yang Y, Lv M, Xu Q, Wang X, Fang Z Int J Nanomedicine. 2024; 19:12593-12614.

PMID: 39619058 PMC: 11606342. DOI: 10.2147/IJN.S491335.

Wildfire-relevant woodsmoke and extracellular vesicles (EVs): Alterations in EV proteomic signatures involved in extracellular matrix degradation and tissue injury in airway organotypic models.

Vitucci E, Carberry C, Payton A, Herring L, Mordant A, Kim Y Environ Res. 2024; 264(Pt 2):120395.

PMID: 39571711 PMC: 11694228. DOI: 10.1016/j.envres.2024.120395.

Timing impact on the initiation of pirfenidone therapy on idiopathic pulmonary fibrosis disease progression.

Mohamed B, Abdelrahim M World J Clin Cases. 2024; 12(32):6538-6542.

PMID: 39554893 PMC: 11438636. DOI: 10.12998/wjcc.v12.i32.6538.

References

Nordin J, Lee Y, Vader P, Mager I, Johansson H, Heusermann W . Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties. Nanomedicine. 2015; 11(4):879-83. DOI: 10.1016/j.nano.2015.01.003. View

An T, Qin S, Sun D, Huang Y, Hu Y, Li S . Unique Protein Profiles of Extracellular Vesicles as Diagnostic Biomarkers for Early and Advanced Non-Small Cell Lung Cancer. Proteomics. 2019; 19(12):e1800160. DOI: 10.1002/pmic.201800160. View

Ghosh A, Davey M, Chute I, Griffiths S, Lewis S, Chacko S . Rapid isolation of extracellular vesicles from cell culture and biological fluids using a synthetic peptide with specific affinity for heat shock proteins. PLoS One. 2014; 9(10):e110443. PMC: 4201556. DOI: 10.1371/journal.pone.0110443. View

Levanen B, Bhakta N, Paredes P, Barbeau R, Hiltbrunner S, Pollack J . Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients. J Allergy Clin Immunol. 2013; 131(3):894-903. PMC: 4013392. DOI: 10.1016/j.jaci.2012.11.039. View

Liu S, Zhan Y, Luo J, Feng J, Lu J, Zheng H . Roles of exosomes in the carcinogenesis and clinical therapy of non-small cell lung cancer. Biomed Pharmacother. 2018; 111:338-346. DOI: 10.1016/j.biopha.2018.12.088. View

Garofalo M, Saari H, Somersalo P, Crescenti D, Kuryk L, Aksela L . Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment. J Control Release. 2018; 283:223-234. DOI: 10.1016/j.jconrel.2018.05.015. View

Lawson J, Dickman C, Towle R, Jabalee J, Javer A, Garnis C . Extracellular vesicle secretion of miR-142-3p from lung adenocarcinoma cells induces tumor promoting changes in the stroma through cell-cell communication. Mol Carcinog. 2018; 58(3):376-387. DOI: 10.1002/mc.22935. View

Geuze H, Slot J, Strous G, Hasilik A, von Figura K . Possible pathways for lysosomal enzyme delivery. J Cell Biol. 1985; 101(6):2253-62. PMC: 2114005. DOI: 10.1083/jcb.101.6.2253. View

Cazzoli R, Buttitta F, Di Nicola M, Malatesta S, Marchetti A, Rom W . microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J Thorac Oncol. 2013; 8(9):1156-62. PMC: 4123222. DOI: 10.1097/JTO.0b013e318299ac32. View

10.

Yuana Y, Levels J, Grootemaat A, Sturk A, Nieuwland R . Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation. J Extracell Vesicles. 2014; 3. PMC: 4090368. DOI: 10.3402/jev.v3.23262. View

11.

Bahmer T, Krauss-Etschmann S, Buschmann D, Behrends J, Watz H, Kirsten A . RNA-seq-based profiling of extracellular vesicles in plasma reveals a potential role of miR-122-5p in asthma. Allergy. 2020; 76(1):366-371. PMC: 7818394. DOI: 10.1111/all.14486. View

12.

Mulcahy L, Pink R, Carter D . Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014; 3. PMC: 4122821. DOI: 10.3402/jev.v3.24641. View

13.

Tian T, Wang Y, Wang H, Zhu Z, Xiao Z . Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy. J Cell Biochem. 2010; 111(2):488-96. DOI: 10.1002/jcb.22733. View

14.

Sercombe L, Veerati T, Moheimani F, Wu S, Sood A, Hua S . Advances and Challenges of Liposome Assisted Drug Delivery. Front Pharmacol. 2015; 6:286. PMC: 4664963. DOI: 10.3389/fphar.2015.00286. View

15.

Carleo A, Bargagli E, Landi C, Bennett D, Bianchi L, Gagliardi A . Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosis. J Breath Res. 2016; 10(2):026007. DOI: 10.1088/1752-7155/10/2/026007. View

16.

Ax E, Jevnikar Z, Cvjetkovic A, Malmhall C, Olsson H, Radinger M . T2 and T17 cytokines alter the cargo and function of airway epithelium-derived extracellular vesicles. Respir Res. 2020; 21(1):155. PMC: 7304225. DOI: 10.1186/s12931-020-01402-3. View

17.

Wang N, Song X, Liu L, Niu L, Wang X, Song X . Circulating exosomes contain protein biomarkers of metastatic non-small-cell lung cancer. Cancer Sci. 2018; 109(5):1701-1709. PMC: 5980308. DOI: 10.1111/cas.13581. View

18.

Makiguchi T, Yamada M, Yoshioka Y, Sugiura H, Koarai A, Chiba S . Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis. Respir Res. 2016; 17(1):110. PMC: 5011900. DOI: 10.1186/s12931-016-0427-3. View

19.

Martin-Medina A, Lehmann M, Burgy O, Hermann S, Baarsma H, Wagner D . Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2018; 198(12):1527-1538. DOI: 10.1164/rccm.201708-1580OC. View

20.

Vogel R, Coumans F, Maltesen R, Boing A, Bonnington K, Broekman M . A standardized method to determine the concentration of extracellular vesicles using tunable resistive pulse sensing. J Extracell Vesicles. 2016; 5:31242. PMC: 5040823. DOI: 10.3402/jev.v5.31242. View